| Autor: |
Dempsey T; Department of Global Public Health, Karolinska Institutet, 17177 Solna, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, 17176 Solna, Sweden., Nguyen HL; Neonatal Department, Phu San Hanoi Hospital, Hanoi 100000, Vietnam., Nguyen HT; Neonatal Department, Phu San Hanoi Hospital, Hanoi 100000, Vietnam., Bui XA; Department of Information Technology, Phu San Hanoi Hospital, Hanoi 100000, Vietnam., Pham PTT; Neonatal Department, Phu San Hanoi Hospital, Hanoi 100000, Vietnam., Nguyen TK; Department of Gynecological Oncology, Phu San Hanoi Hospital, Hanoi 100000, Vietnam.; Department of International Collaboration, Phu San Hanoi Hospital, Hanoi 100000, Vietnam., Cavallin F; Independent Researcher, 36020 Solagna, Italy., Trevisanuto D; Department of Woman's and Child's Health, University Hospital of Padova, 35128 Padova, Italy., Myrnerts Höök S; Department of Global Public Health, Karolinska Institutet, 17177 Solna, Sweden.; Emergency Care Unit, Sachs' Children and Youth Hospital, 11883 Stockholm, Sweden., Pejovic N; Department of Global Public Health, Karolinska Institutet, 17177 Solna, Sweden.; Neonatal Unit, Sachs' Children and Youth Hospital, 11883 Stockholm, Sweden., Blennow M; Department of Clinical Science Intervention and Technology, Karolinska Institutet, 14152 Huddinge, Sweden., Olson L; Department of Global Public Health, Karolinska Institutet, 17177 Solna, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, 17177 Solna, Sweden.; Department of Medical Biochemistry and Microbiology, Uppsala University, 75237 Uppsala, Sweden., Vu H; Department of International Collaboration, Phu San Hanoi Hospital, Hanoi 100000, Vietnam.; Intensive Care Unit and Poison Control Department, Phu San Hanoi Hospital, Hanoi 100000, Vietnam.; Social Work Department, Phu San Hanoi Hospital, Hanoi 100000, Vietnam.; University of Medicine and Pharmacy, Hanoi 100000, Vietnam., Nguyen AD; University of Medicine and Pharmacy, Hanoi 100000, Vietnam.; Board of Directors, Phu San Hanoi Hospital, Hanoi 100000, Vietnam., Alfvén T; Department of Global Public Health, Karolinska Institutet, 17177 Solna, Sweden.; Emergency Care Unit, Sachs' Children and Youth Hospital, 11883 Stockholm, Sweden. |
| Abstrakt: |
Every year, 2.4 million neonates die during their first month of life and even more suffer permanent injury. The main causes are intrapartum-related events, prematurity, and infection, with sub-Saharan Africa and southern Asia being the worst affected regions. With a focus on intrapartum-related events, we aimed to assess the neonatal demographic characteristics, clinical management, and outcomes among neonates born at the largest obstetric hospital in Hanoi, Vietnam. This was a retrospective cross-sectional study that included all the inborn neonates in November 2019, which was selected as a representative month. A total of 4554 neonates were born during the study period. Of these, 1.0% ( n = 44) were stillbirths, 0.15% ( n = 7) died in hospital, 0.61% ( n = 28) received positive pressure ventilation at birth, and 0.15% ( n = 7) were diagnosed with hypoxic ischemic encephalopathy. A total of 581 (13%) neonates were admitted to the neonatal unit, among which the most common diagnoses were prematurity (37%, n = 217) and infection (15%, n = 89). Except for the intrapartum-related events, our findings are consistent with the previously documented data on neonatal morbidity. The intrapartum-related events, however, were surprisingly low in number even in comparison to high-income countries. Research on the current clinical practice at Phu San Hanoi Hospital may bring further clarity to identify the success factors. |
